Hashimoto Ensefalopatisi

Ferracci F, Bertiato G, Moretto G. Hashimoto`s encephalopathy: epidemiological data and pathogenetic considerations. J Neurol Sci. 2004;217:165–8.

Patnaik SK, Upreti V, Dhull P. Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) in childhood. J Pediatr Endocrinol Metab. 2014;27:737-44.

Brain, L.; Jellinek, E.H.; Ball, K. Hashimoto’s disease and encephalopathy. Lancet 1966;2:512–4.

Laurent C, Capron J, Quillerou B. Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature. Autoimmun. Rev. 2016; 15, 1129–33.

Mocellin R, Walterfang M, Velakoulis D. Hashimoto’s encephalopathy: Epidemiology, pathogenesis and management. CNS Drugs 2007; 21,799–811.

Olmez I, Moses H, Sriram S, Kirshner H, Lagrange AH, Pawate S. Diagnostic and therapeutic aspects of Hashimoto’s encephalopathy. J. Neurol. Sci. 2013; 331: 67–71.

Kothbauer-Margreiter I, Sturzenegger M, Komor J. et al. Encephalopathy associated with Hashimoto thyroiditis: Diagnosis and treatment. J Neurol. 1996;243: 585–93.

Grani G, Carbotta G, Nesca A, D’Alessandri M, Vitale M, Del Sordo M, Fumarola A. A comprehensive score to diagnose Hashimoto’s thyroiditis: A proposal. Endocrine. 2015; 49:361–65.

Ferracci F, Moretto G, Candeago RM, Cimini N, Conte F, Gentile et. al. Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto's encephalopathy. Neurology. 2003;25;60(4):712-4.

Ferracci, F., Bertiato, G., & Moretto, G. Hashimoto’s encephalopathy: epidemiologic data and pathogenetic considerations. Journal of the Neurological Sciences. 2004;217(2), 165–8.

Benvenga S, Guarneri F. Homology between TSH-R/Tg/TPO and Hashimoto's encephalopathy autoantigens. Front Biosci (Landmark Ed). 2020;1;25(2):229-41.

Fujii A, Yoneda M, Ito T, Yamamura O, Satomi S, Higa H, Kimura A, Suzuki M, Yamashita M, Yuasa T, Suzuki H, Kuriyama M. Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy. J Neuroimmunol. 2005;162(1-2):130-6.

Forchetti CM, Katsamakis G, Garron DC. Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology. 1997;49(2):623-6.

Laurent C, Capron J, Quillerou B. Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature. Autoimmun. Rev. 2016; 15, 1129–33

Gayatri NA, Whitehouse WP.Pilot survey of Hashimoto’s encephalopathy in children. Dev Med Child Neurol. 2005;47:556–558

Boelen R, de Vries T. Clinical characteristics of paediatric Hashimoto's encephalopathy. Eur J Paediatr Neurol. 2021;32:122-27.

Erol I, Saygi S, Alehan F. Hashimoto's encephalopathy in children and adolescents. Pediatr Neurol. 2011;45(6):420-2.

Chiarello P, Talarico V, Nicoletti A, Rodio B, Arcuri PP, Bosco D, Gigliotti F, Galati MC, Raiola G. Hashimoto encephalopathy: a case report and a short revision of current literature. Acta Biomed. 2020;91:e2020087.

Taurin G, Golfier V, Pinel JF, Deburghgraeve V, Poirier JY, Edan G, Vérin M. Choreic syndrome due to Hashimoto's encephalopathy. Mov Disord. 2002;17(5):1091-2.

Dumrikarnlert C, Thakolwiboon S, Senanarong V. Clinical presentations and treatment outcomes of Hashimoto encephalopathy at Siriraj Hospital - Thailand's largest national tertiary referral center. BMC Neurol. 2023;22;23(1):334.

Shaw PJ, Walls TJ, Newman PK, et al. Hashimoto’s encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers—report of 5 cases. Neurology. 1991;41(2pt1):228–33.

Pempera N, Miedziaszczyk M, Lacka K. Difficulties in the Diagnostics and Treatment of Hashimoto's Encephalopathy-A Systematic and Critical Review. Int J Mol Sci. 2024;28;25(13):7101.

Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002 Feb;87(2):489-99.

Adams AV, Mooneyham GC, Van Mater H, Gallentine W. Evaluation of Diagnostic Criteria for Hashimoto Encephalopathy Among Children and Adolescents. Pediatr Neurol. 2020 Jun;107:41-47.

Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006;63(2):197-202.

Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol. 2003;60(2):164-71.

Schäuble B, Castillo PR, Boeve BF, Westmoreland BF. EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol. 2003 Jan;114(1):32-7.

Song YM, Seo DW, Chang GY. MR findings in Hashimoto encephalopathy. AJNR Am J Neuroradiol. 2004;25(5):807-8.

Pozo-Rosich P, Villoslada P, Canton A, Simo R, Rovira A, Montalban X. Reversible white matter alterations in encephalopathy associated with autoimmune thyroid disease. J Neurol. 2002;249(8):1063-5.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016 Apr;15(4):391-404.

Gulen GM, Horoz OO, Herguner MO, et al. Hashimoto’s encephalopathy: four cases and review of literature. Int J Neurosci. 2014;124:302e306.

Bruns A, Meyer O. Neuropsychiatric manifestations of systemic lupus erythematosus. Joint Bone Spine. 2006;73(6):639-45.

Imbesi SG. Diffuse cerebral vasculitis with normal results on brain MR imaging. AJR Am J Roentgenol. 1999 Dec;173(6):1494-6.

Johnson RT, Gibbs CJ Jr. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med. 1998 Dec 31;339(27):1994-2004. doi: 10.1056/NEJM199812313392707. PMID: 9869672.

Marshall GA, Doyle JJ. Long-term treatment of Hashimoto's encephalopathy. J Neuropsychiatry Clin Neurosci. 2006;18(1):14-20.

Nagpal T, Pande S. Hashimoto's encephalopathy: response to plasma exchange. Neurol India. 2004 Jun;52(2):245-7.

Şorodoc V, Constantin M, Asaftei A, Lionte C, Ceasovschih A, Sîrbu O, Haliga RE, Şorodoc L. The use of intravenous immunoglobulin in the treatment of Hashimoto's encephalopathy: case based review. Front Neurol. 2023;7;14:1243787.